Breakthrough Innovations in Regenerative Medicine Target Parkinson's, Heart Disease, and AMD
• A revolutionary biodegradable heart valve scaffold developed by researchers at Harefield Hospital and Imperial College London shows promise in animal trials, potentially eliminating the need for repeated valve replacements.
• Stem cell therapy for Parkinson's disease demonstrates encouraging safety data in the STEM-PD trial, with transplanted dopamine cells showing survival for 6-12 months post-transplantation.
• Adverum Biotechnologies' single-dose gene therapy ixo-vec for wet AMD advances to Phase III trials, offering an alternative to monthly eye injections.
Revolutionary Heart Valve That Grows Inside the Body to be Tested in UK
A groundbreaking development in regenerative medicine, a heart valve that grows inside the body, is set to be tested on British cardiac patients. This innovation, led by Professor Sir Magdi Yacoub, promises a significant advancement for treating congenital heart defects in children, as the valve grows with the patient, eliminating the need for repeated surgeries.
© Copyright 2025. All Rights Reserved by MedPath